-
2023-508072-11-00
Castration-resistant prostate cancer 2019-06-26
-
2024-510580-28-00
Middle or low locally advanced resectable rectal carcin 2019-06-05
-
2024-512444-29-00
patients who will undergo kidney, liver or kidney-pancr 2019-05-07
-
2024-512173-27-00
Advanced (stage IIIB/IIIC/IV) NSCLC patients eligible f 2019-03-21
-
2024-512034-14-00
severe trauma 2019-03-04
-
2023-509489-39-00
Resectable, non-metastatic soft-tissue sarcoma (STS) 2019-02-05
-
2024-514094-22-00
Intrecerebral Haemorrhage 2019-01-18
-
2024-513022-29-00
Major Depression Disorders 2019-01-09
-
2023-506857-40-00
Prostate Cancer 2019-01-08
-
2024-516320-33-00
Bladder cancer 2019-01-07
-
2023-504917-54-00
Biochemical recurrence after prostate cancer surgery 2018-10-30
-
2022-501254-10-00
Advanced tumors 2018-08-24
-
2024-516110-38-00
Hepatoblastoma and Hepatocellular Carcinoma 2018-03-06
-
2024-518578-15-00
Is to demonstrate a non inferior efficacy of azithromyc 2018-02-05
-
2023-504520-26-00
Duchenne Muscular Dystrophy (DMD) 2017-10-19
-
2024-517236-22-00
Intradural saccular unruptured aneurysm 2017-09-20
-
2023-508128-37-00
All patients who have been treated with Novartis or Pen 2017-07-19
-
2024-514556-32-00
Adult critically ill patients with severe vitamin D def 2017-02-15
-
2024-516196-32-00
breast cancer 2017-01-01
-
2024-515432-71-00
gastrointestinal stromal tumor 2016-09-13
-
2023-506027-29-00
Children, adolescents and adults with newly diagnosed d 2014-10-01
-
2024-516358-23-00
Gastric adenocarcinoma 2013-06-24
-
2024-518254-16-00
Acute Myeloid Leukemia (Pediatric 0-18 years) 2013-03-01
-
2024-517390-24-00
Ovarian epithelial cancer : intraperitoneal resectable 2011-04-26